Code
|
2741D
|
MA number
|
EU/1/16/1124/066
|
Product Form:
|
sol inj 12(3x4)x0,7 ml/17,5 mg (pero napl.)
|
MA Status:
|
E - Valid centralised marketing authorisation
|
Type of procedure:
|
EU
|
MAH, country:
|
Nordic Group B.V., Netherland
|
Therapeutic Class:
|
29 - ANTIRHEUMATICA, ANTIPHLOGISTICA, ANTIURATICA
|
ATC:
|
L |
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS |
L04 |
Immunosuppressants |
L04A |
Immunosuppressants |
L04AX |
Other immunosuppressants |
L04AX03 |
Methotrexate |
|
Shelf life:
|
24 |
Container:
|
pre-filled pen
|
Route of admin.:
|
Subcutaneous use
|